Opus Genetics, Inc. · NASDAQ:IRD
Zaremba Rabourn Amy sold 1,641 Opus Genetics, Inc. shares (Form 4)
Traded Apr 23, 2026 · Filed Apr 27, 2026
On Apr 23, 2026, Zaremba Rabourn Amy (Head of Fin. Quality Assurance) sold 1,641 Opus Genetics, Inc. shares at US$5.20 for US$8,533, leaving 188,671 shares. Filed Apr 27, 2026 (Form 4).
- Sold
- 1,641 shares
- Price
- US$5.20
- Value
- US$8,533
- Holding after
- 188,671 shares
- Trading plan
- No
- Role
- Head of Fin. Quality Assurance
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 23, 2026 | Common Stock | Sale | 1,641 | US$5.20 | 188,671 | Direct |
Source
Related
- Opus Genetics, Inc.
- Zaremba Rabourn Amy
- Opus Genetics, Inc. shareholders
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · Oct 2, 2026
- Form 4 · Magrath George · Sep 11, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Form 4 · Gagnon Robert E. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026